Frank A. Hoffmann
Halle, NI, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Reduced Hospital Incidence of Autoimmune Encephalitis During the COVID-19 Pandemic.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 13, 2026
An MSA-P patient presenting with preserved glucose metabolism in the putamen, cerebellar hypometabolism and pronounced loss of presynaptic dopamine transporter in the striatum.
Journal: EJNMMI reports
Published: November 17, 2025
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS).
Journal: European journal of neurology
Published: August 12, 2025
Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis: A Multicenter Cohort Study.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 07, 2025
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study).
Journal: Frontiers in immunology
Published: February 12, 2025
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2.
Journal: Journal of neurology
Published: December 09, 2024
Long-term efficacy and safety of alemtuzumab in participants with highly active MS: TOPAZ clinical trial and interim analysis of TREAT-MS real-world study.
Journal: Therapeutic advances in neurological disorders
Published: June 14, 2024
Infections and multiple sclerosis
Journal: Fortschritte der Neurologie-Psychiatrie
Published: May 08, 2024
Apixaban versus Aspirin for Embolic Stroke of Undetermined Source.
Journal: NEJM evidence
Published: February 06, 2024
Ability of patients with acute ischemic stroke to recall given information on intravenous thrombolysis: Results of a prospective multicenter study.
Journal: European stroke journal
Published: October 03, 2022
Headache in Multiple Sclerosis - Pharmacological Aspects.
Journal: Current pharmaceutical design
Published: February 22, 2021
Last Updated: 09/26/2026